Search for Clinical Trial Results
Myasthenia Gravis - 34 Studies Found
Status | Study |
Completed |
Study Name: Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis Condition: Myasthenia Gravis Date: 2006-03-21 Interventions: Drug: Intravenous ImmuneGlobulin |
Recruiting |
Study Name: Exercise for Stable Myasthenia Gravis Condition: Myasthenia Gravis Date: 2010-01-12 Interventions: Other: Exercise 3 month exercise intervention, three days |
Active, not recruiting |
Study Name: Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis Condition: Myasthenia Gravis Date: 2009-09-29 Interventions: Drug: Prednisone - Azathioprine Rapid strategy consists of |
Recruiting |
Study Name: Benefits and Tolerance of Exercise in Patients With Generalized and Stabilized Myasthenia Gravis Condition: Myasthenia Gravis Date: 2014-01-13 Interventions: Behavioral: Physical exercise programme using a rowing machine 3 sessions per week of individualized phy |
Completed |
Study Name: Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy Condition: Myasthenia Gravis Date: 2006-02-21 Interventions:
|
Completed |
Study Name: A Pilot Trial of Rituxan in Refractory Myasthenia Gravis Condition: Refractory Myasthenia Gravis Date: 2008-01-14 Interventions: Drug: Rituximab (Rituxan) Four weekly IV infusions of Rituxan with dosage individually calculated per su |
Active, not recruiting |
Study Name: Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis Condition: Myasthenia Gravis Date: 2015-11-13 Interventions:
|
Terminated |
Study Name: Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis Condition: Myasthenia Gravis Date: 2011-11-01 Interventions: Drug: Subcutaneous immunoglobulins Immunoglobulins used subcutaneously for maintenance of other immune m |
Recruiting |
Study Name: Trial of Orencia in Patients With Myasthenia Gravis Condition: Myasthenia Gravis Date: 2017-02-17 Interventions: Drug: Abatacept Injection Subcutaneous administration of abatacept |
Recruiting |
Study Name: Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis Condition: Myasthenia Gravis Date: 2014-03-27 Interventions: Drug: HIZENTRA ® Other Name: Immune Globulin Subcutaneous (Human), 20% Liquid |